BIRC5 and chronic myelogenous leukemia, BCR-ABL1 positive: Interestingly, broadening of survivin fluorescence intensity distribution was detectable in DAC + SAHA-treated CML-T1 cells, irrespective of the absence of protein level change in immunoblot-visualized overall expression.